series-b
Stage
1
Investors
About
Cadent Therapeutics is a biotechnology company developing therapies for neurological and neuropsychiatric disorders by targeting neurons that control brain circuits.
Explore Cadent Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.